Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lack of efficacy of clarithromycin in advanced multiple myeloma. Intergroupe Français du Myélome (IFM)

× No keyword cloud information.

6 in total

1. Phase II trial of clarithromycin and pamidronate therapy in myeloma.

Authors: T C Morris; L Ranaghan; J Morrison
Journal: Med Oncol Date: 2001 Impact factor: 3.064

2. Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent.

Authors: An Mt Van Nuffel; Vidula Sukhatme; Pan Pantziarka; Lydie Meheus; Vikas P Sukhatme; Gauthier Bouche
Journal: Ecancermedicalscience Date: 2015-02-24

Review 3. Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma.

Authors: Caterina Musolino; Alessandro Allegra; Vanessa Innao; Andrea Gaetano Allegra; Giovanni Pioggia; Sebastiano Gangemi
Journal: Mediators Inflamm Date: 2017-09-26 Impact factor: 4.711

4. Human bone marrow niche chemoprotection mediated by cytochrome P450 enzymes.

Authors: Salvador Alonso; Meng Su; Jace W Jones; Sudipto Ganguly; Maureen A Kane; Richard J Jones; Gabriel Ghiaur
Journal: Oncotarget Date: 2015-06-20

5. A novel combination of bortezomib, lenalidomide, and clarithromycin produced stringent complete response in refractory multiple myeloma complicated with diabetes mellitus - clinical significance and possible mechanisms: a case report.

Authors: Nobuo Takemori; Goro Imai; Kazuo Hoshino; Akishi Ooi; Masaru Kojima
Journal: J Med Case Rep Date: 2018-02-18

6. Roxithromycin monotherapy inducing a partial response in a patient with myeloma: a case report.

Authors: Kern Y Chai; Anna L Byrne; Ian M Morison
Journal: J Med Case Rep Date: 2018-05-10

6 in total